DXTERITY

Welcome to the Brand page for “DXTERITY”, which is offered here for In the statement, line 1, dxterity diagnostics, inc. should be deleted and dxterity diagnostics incorporated, should be inserted.;diagnostic biomarker reagents for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, autoimmune disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, cancer; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; all of the foregoing for use in connection with genomic molecular diagnostic testing;dx terity;diagnostic preparations for scientific or research use; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; diagnostic preparations for scientific or research use other than for medical use; diagnostic preparations for scientific use; diagnostic preparations other than for medical or veterinary purposes; diagnostic preparations used in science; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; all of the foregoing for use in connection with genomic molecular diagnostic testing;medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of biodosimetry; medical testing for diagnostic or treatment purposes in the field of cancer; medical testing for diagnostic or treatment purposes in the field of autoimmune disease; all of the foregoing for use in connection with genomic molecular diagnostic testing;blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; blood testing apparatus, blood collecting tubes; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; medical specimen collection devices in the nature of fingerstick device for the collection of blood; medical specimen collection devices in the nature of evacuated tube for the collection of blood; all of the foregoing for use in connection with genomic molecular diagnostic testing;.

Its status is currently believed to be active. Its class is unavailable. “DXTERITY” is believed to be currently owned by “DXTERITY DIAGNOSTICS INCORPORATED”.